The number of people with susceptibility test result for rifampicin in Netherlands
Netherlands: The number of people with susceptibility test result for rifampicin was 270 in 2021. ▼ Falling
Latest (2021)
270
Change on year
up 10.7%
World rank
88th
of 155 countries
All-time high
354
in 2017
All-time low
244
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Netherlands, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Netherlands is 270, measured in 2021.
The figure is up 10.7% on the previous year and down 23.7% over five years.
That places Netherlands 88th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Netherlands, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 354 | — |
| 2018 | 326 | -7.9% |
| 2019 | 287 | -12.0% |
| 2020 | 244 | -15.0% |
| 2021 | 270 | +10.7% |
Netherlands compared with similar countries
- Netherlands's 270 is above the median for high income countries, which is 142, 1.9× the median. (61 countries reporting)
- Netherlands's 270 is above the median for Europe & Central Asia, which is 229.5, 1.2× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 322.33 | 287 | 354 | 3 |
| 2020s | 257 | 244 | 270 | 2 |
Countries ranked near Netherlands
More health data for Netherlands
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1866 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.4989 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0239 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5005 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Netherlands?
- The number of people with susceptibility test result for rifampicin in Netherlands was 270 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Netherlands?
- The highest recorded value was 354 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Netherlands?
- The lowest recorded value was 244 in 2020.
- How does Netherlands rank for the number of people with susceptibility test result for rifampicin?
- Netherlands ranks 88th out of 155 countries with data for 2021.
- Where does this Netherlands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).